Fermatex Vascular Technologies Inc.02.05.18
Fermatex Vascular Technologies Inc. (formerly Gore-Jersey Shore and most notably Adam Spence Corporation), a supplier of reinforced medical tubing and catheter subassemblies, has hired Steve Maxson as vice president. Maxson will be responsible for all sales, marketing and customer service activities for the company.
“I’m very pleased to have Steve join the Fermatex team at this exciting time of transition and growth. His technical experience and commitment to responsive service will ensure that we remain focused on our customers’ needs and continue to deliver the highest quality medical tubing solutions to our medical device customers,” said Mike Janish, CEO of Fermatex.
Maxson joins Fermatex with more than 20 years experience in extrusion and medical component manufacturing, most recently as director of global business development at American Kuhne, where he was responsible for sales, marketing, product development and merger and acquisition activities.
“I am very excited to become part of the Fermatex team. The company’s extrusion technology and technical expertise is legendary and highly valued by our medical device customers,” Maxson said. “I am proud to be part of the next chapter in this storied company’s history.”
Fermatex designs and manufactures highly-engineered medical extrusions, braid reinforced extrusions and catheter sub-assemblies for many of the world’s medical device OEMs. Originally founded as Adam Spence Corporation in 1960, the company was acquired by W.L. Gore in 2004 and sold to Vance Street Capital in 2017. The company was a pioneer in the contract design and manufacture of medical devices and has been providing extrusions to the medical device industry for more than 55 years.
Vance Street Capital is a Los Angeles, Calif.-based private equity firm that invests in middle-market businesses in the medical, aerospace, defense and industrial sectors. For more than two decades, Vance Street’s partners have worked with management, family owners and other co-investors to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolios.
“I’m very pleased to have Steve join the Fermatex team at this exciting time of transition and growth. His technical experience and commitment to responsive service will ensure that we remain focused on our customers’ needs and continue to deliver the highest quality medical tubing solutions to our medical device customers,” said Mike Janish, CEO of Fermatex.
Maxson joins Fermatex with more than 20 years experience in extrusion and medical component manufacturing, most recently as director of global business development at American Kuhne, where he was responsible for sales, marketing, product development and merger and acquisition activities.
“I am very excited to become part of the Fermatex team. The company’s extrusion technology and technical expertise is legendary and highly valued by our medical device customers,” Maxson said. “I am proud to be part of the next chapter in this storied company’s history.”
Fermatex designs and manufactures highly-engineered medical extrusions, braid reinforced extrusions and catheter sub-assemblies for many of the world’s medical device OEMs. Originally founded as Adam Spence Corporation in 1960, the company was acquired by W.L. Gore in 2004 and sold to Vance Street Capital in 2017. The company was a pioneer in the contract design and manufacture of medical devices and has been providing extrusions to the medical device industry for more than 55 years.
Vance Street Capital is a Los Angeles, Calif.-based private equity firm that invests in middle-market businesses in the medical, aerospace, defense and industrial sectors. For more than two decades, Vance Street’s partners have worked with management, family owners and other co-investors to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolios.
